Optimize your oncology practice with real-time patient data

Provide personalized care, boost work efficiency, and gain actionable insights with Elekta’s electronic patient-reported outcomes (ePROs)

Learn more

Tailored digital health solutions for every cancer patient

Elekta's ePROs platform, Elekta ONE Patient Companion, allows patients to instantly share updates on their symptoms, health, and quality of life. This real-time data empowers oncologists to track patient progress, improve quality of care, and optimize resources.

Book a demo
Kaiku open on 3 devices

Why use ePROs in your clinical practice?

Personalized care, made easy

Digital patient monitoring bridges the gap between cancer patients and their care teams. With therapy-specific modules and predictive algorithms for over 25 cancer types, patients get automatic, personalized guidance based on their reported symptoms. Integrated with MOSAIQ, these tailored modules improve patient safety while saving medical staff’s time.

Kaiku open on an ipad
Patient companion on a laptop

Prevent healthcare worker burnout

With cancer cases increasing and a global shortage of healthcare professionals, digital patient monitoring is crucial for optimizing care and ensuring your team’s wellbeing. By automating symptom and quality of life questionnaires as well as real-time patient feedback, you can lighten your staff's workload, reduce time-consuming phone calls, and enhance patient self-management.

Embrace the future of patient engagement

Digital solutions are the new normal, shaping patient care standards. By leveraging the power of AI and machine learning, you’ll get the real-time data you need to make smarter treatment decisions. Track real-world outcomes, compare therapy efficacies, and drive institutional research—all while catching symptoms early to avoid ER visits.

Patient Companion software on an ipad

The power of ePROs at a glance

57% reduction in phone call burden for healthcare systems 1

Self-management recommendations perceived by patients as “very helpful” 2

98% of patients report the platform is easy to use, with a high adoption rate among older users across geographies 1, 3

Download our brochure

Don’t just take our word for it

The European Journal of Cancer

A 2024 article in The European Journal of Cancer - Skin Cancer highlights that our ePROs significantly enhance health-related quality of life (HRQOL) and effectively forecast the onset of symptoms using our prediction algorithm.

Read the article

Ellinor Haukland

MD, PhD, Clinical Oncologist Nordland Hospital Trust, Norway

“Elekta ONE Patient Companion helps us work more efficiently and provide safer treatment, which is important as we see more and more cancer patients.”

Read the full story

Ricardo M. Ruggeri

M. Sc. Medical Physics and Technical Oncology Director of Leben Salud

“Patient Companion offers us, as an institution, a clinical follow-up tool for our patients, with the peace of mind of providing secure and useful information for their treatment.”

Read the article

Judith Lijnsvelt

Nurse Practitioner at the Netherlands Cancer Institute

“It only takes about two minutes for them to complete all the questionnaires.”

Webinar

Leveraging ePROs for smarter care

During the webinar, you will:

  • Learn how Elekta's ePROs tool is optimizing workflows in a clinical setting
  • Gain an understanding of how AI and machine learning tools can help ease the burden on staff
  • Uncover how real world outcomes are impacting the future of cancer care

Donna Sternberg
RN, BSN, OCN, Chief Nurse, Hampton University Proton Cancer Institute
Virginia, USA

Sign up

Curious about ePROs for your practice?

Book a demo to see how Elekta ONE Patient Companion could make a difference for you and your clinic.

Book a demo

Elekta ONE | Patient Companion powered by Kaiku Health is not available in all markets.

References

  1. Iivanainen, S. M. E., Ravi, R., Jekunen, A., Arokoski, R., Ekstrom, J., Mentu, S., Virtanen, H., Kataja, V., & Koivunen, J. P. (2021). 1695P ePRO follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care. In Annals of Oncology (Vol. 32, pp. S1184–S1185). Elsevier BV. https://doi.org/10.1016/j.annonc.2021.08.1667
  2. Eicher, M., Bana, M., Ribi, K., Schneider, S., & Ammann, J. (2023). Use and value of self-management (SM) recommendations in a real-world evidence study evaluating digital patient monitoring (DPM) of patients (pts) receiving cancer care. In Journal of Clinical Oncology (Vol. 41, Issue 16_suppl, pp. 1603–1603). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2023.41.16_suppl.1603
  3. Data maintained internally by Elekta